Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000893220-08-000772
Filing Date
2008-03-20
Accepted
2008-03-20 07:52:25
Documents
7
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K w51622e10vk.htm 10-K 560967
2 LIST OF SUBSIDIARIES w51622exv21w1.htm EX-21.1 5391
3 CEO CERTIFICATION PURSUANT TO SECTION 302 w51622exv31w1.htm EX-31.1 7670
4 CFO CERTIFICATION PURSUANT TO SECTION 302 w51622exv31w2.htm EX-31.2 7926
5 CEO CERTIFICATION PURSUANT TO SECTION 906 w51622exv32w1.htm EX-32.1 3311
6 CFO CERTIFICATION PURSUANT TO SECTION 906 w51622exv32w2.htm EX-32.2 3339
7 GRAPHIC w51622w5162201.gif GRAPHIC 4162
  Complete submission text file 0000893220-08-000772.txt   595925
Mailing Address 520 VIRGINIA DRIVE FORT WASHINGTON PA 19034
Business Address 520 VIRGINIA DRIVE FORT WASHINGTON PA 19034 215-540-0700
RESEARCH PHARMACEUTICAL SERVICES, INC. (Filer) CIK: 0001420070 (see all company filings)

EIN.: 204322769 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-52981 | Film No.: 08700695
SIC: 8731 Services-Commercial Physical & Biological Research